ITGB4 and breast carcinoma: The combination of CD104 and CD44 markers have been used in basal breast cancer cells to identify epithelial (E) (CD104+CD44low), Hybrid E/M (CD104+CD44high) and mesenchymal (xM) (CD104-CD44high) cell populations [7].